跳至主要内容
临床试验/IRCT20231108059991N1
IRCT20231108059991N1招募中Unknown

Evaluation of employing hypothermia for prevention of chemotherapy-induced peripheral neuropathy (CIPN)

Sabzevar University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
Female

入选标准

  • Consent to use the cooling device and complete the consent form
  • The use of one of the chemotherapy regimens with the occurrence of neuropathy including drugs from the taxanes
  • Performance more than 70%
  • Age less than 75 years

排除标准

  • History of melanoma
  • History of systemic lupus erythematosus
  • Poor controlled diabetes
  • Dissatisfaction with using the device
  • History of cryoglobulinemia

研究者

发起方
Sabzevar University of Medical Sciences

相似试验